Patents by Inventor Thomas J. Webster

Thomas J. Webster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951124
    Abstract: Tellurium nanowires synthesized using green chemistry methods and having unique morphologies and functional properties are provided. The nanowires have a core of hexagonal crystal phase tellurium and a polymer coating, and can be used for treating cancer without apparent cytotoxicity toward normal human cells.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: April 9, 2024
    Assignee: Northeastern University
    Inventors: David Medina Cruz, Ada Vernet Crua, Thomas J. Webster
  • Publication number: 20240108572
    Abstract: A material includes a metallic, nanoporous structure having a plurality of nanopores having a porosity that allows passage of insulin but not IgG. The metallic nanoporous structure includes titanium, 316L stainless steel and may have a textured nano-sericeous surface. A nanoporous bicontinuous structure can be integrated with nanopores.
    Type: Application
    Filed: December 13, 2023
    Publication date: April 4, 2024
    Inventors: Willard W. HENNEMANN, Bryan L. STEELMAN, Thomas J. WEBSTER, Janet E. DAVIS
  • Patent number: 11857670
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: January 2, 2024
    Assignee: NanoVault Medical, LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • Patent number: 11857672
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: January 2, 2024
    Assignee: NanoVault Medical, LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • Patent number: 11857673
    Abstract: A material includes a metallic, nanoporous structure having a plurality of nanopores having a porosity that allows passage of insulin but not IgG. The metallic nanoporous structure includes titanium, 316L stainless steel and may have a textured nano-sericeous surface. A nanoporous bicontinuous structure can be integrated with nanopores.
    Type: Grant
    Filed: October 24, 2022
    Date of Patent: January 2, 2024
    Assignee: NanoVault Medical, LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • Publication number: 20230311563
    Abstract: The present invention is directed to methods for inhibiting growth of bacteria and to nanometer scale surfaces having antibacterial properties.
    Type: Application
    Filed: December 23, 2022
    Publication date: October 5, 2023
    Inventor: Thomas J. WEBSTER
  • Publication number: 20230059851
    Abstract: A material includes a metallic, nanoporous structure having a plurality of nanopores having a porosity that allows passage of insulin but not IgG. The metallic nanoporous structure includes titanium, 316L stainless steel and may have a textured nano-sericeous surface. A nanoporous bicontinuous structure can be integrated with nanopores.
    Type: Application
    Filed: October 24, 2022
    Publication date: February 23, 2023
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • Patent number: 11559556
    Abstract: Methods disclosed herein provide for an environmentally-friendly approach that employ citric extracts from fruits as unique reducing and stabilizing agents for making a tellurium nanomaterial. A particular method of making a tellurium nanomaterial includes combining citrus fruit extract with a tellurium salt to form a mixture of citrus fruit extract and dissolved tellurium salt; and heating the mixture of citrus fruit extract and dissolved tellurium salt, thereby making the tellurium nanomaterial. The resulting nanoparticles exhibit enhanced and desirable biomedical properties toward treatment of both infectious diseases and cancer.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: January 24, 2023
    Assignee: Northeastern University
    Inventors: David Medina Cruz, William Tien-Street, Bohan Zhang, Xinjing Huang, Ada Vernet Crua, Thomas J. Webster
  • Patent number: 11560014
    Abstract: The present invention is directed to methods for inhibiting growth of bacteria and to nanometer scale surfaces having antibacterial properties.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: January 24, 2023
    Assignee: Brown University
    Inventor: Thomas J. Webster
  • Publication number: 20220233458
    Abstract: Green-synthesized tellurium nanowires (GREEN-TeNWs) are generated using a biopolymer as a unique reducing agent, purified, and used as a template for the growth of coated palladium nanoparticles (PdNPs) and platinum nanoparticles (PtNPs) on top of the GREEN-TeNWs, in a reaction that can take place in seconds, with no need for high temperature, stirring, or for additional reducing agent. The heterogeneous structure can contain palladium oxide or platinum oxide. The green-synthesized PdNPs-TeNWs (palladium nanoparticles with tellurium nanowires) and PtNPs-TeNWs (platinum nanoparticles with tellurium nanowires) show potential biomedical applications as antibacterial, anticancer, and antioxidant agents, and show low cytotoxicity for healthy human cells.
    Type: Application
    Filed: June 1, 2020
    Publication date: July 28, 2022
    Inventors: David Medina CRUZ, Ada Vernet CRUA, Thomas J. WEBSTER
  • Publication number: 20220226548
    Abstract: Aspects of the invention relate to a metal material and product made from the metal material having biological properties, such as antibiotic properties.
    Type: Application
    Filed: September 27, 2019
    Publication date: July 21, 2022
    Applicant: KOMATSUSEIKI KOSAKUSHO CO., LTD.
    Inventors: Fumie Yusa, Thomas J. Webster, Takafumi Komatsu
  • Publication number: 20220227810
    Abstract: Disclosed are peptides comprising an amphiphilic backbone and a cationic heparin-binding motif peptide. The peptides can be used in methods of antimicrobial treatment.
    Type: Application
    Filed: November 12, 2021
    Publication date: July 21, 2022
    Inventors: Run Chang, Keerthana Subramanian, Mian Wang, Thomas J. Webster
  • Publication number: 20220218741
    Abstract: Human dermal fibroblasts (HDF) and melanoma (MEL) cells are used herein for synthesis of metal nanoparticles. For example, synthesis of nanoparticles of gold (Au), palladium (Pd), platinum (Pt), and bimetallic formulations of gold-palladium (AuPd) and gold-platinum (AuPt) is demonstrated with HDF and MEL using a straightforward, eco-friendly and cost-effective approach. The nanostructures are purified and used in biomedical tests, which show selective behavior. The production of nanoparticles allows for stopping of the growth of cancer cells and the ability of new healthy cells to grow on top. The production of nanoparticles with the cells allows for an environmental-resistance behavior within the cells, showing the ability to stand for extreme environmental conditions.
    Type: Application
    Filed: June 1, 2020
    Publication date: July 14, 2022
    Inventors: David Medina CRUZ, Junjiang CHEN, Thomas J. WEBSTER
  • Publication number: 20220175827
    Abstract: Selenium (Se) nanostructures are synthesized using bacteria, and the synthetic method provides options for specific functionalization of the nanostructures, targeting, as well as options for crystal form of and for additives to the composition. In addition to drug delivery and imaging options, the synthesized Se nanostructures provide methods of inhibiting drug resistant bacterial cells and cancer cells without cytotoxicity towards normal human cells and dermal fibroblasts. The green chemistry methods for synthesizing Se nanostructures do not produce toxic byproducts and do not require toxic reagents in comparison to traditional chemical synthetic methods for making Se nanostructures, while simultaneously producing new therapeutic benefits and treatments.
    Type: Application
    Filed: April 6, 2020
    Publication date: June 9, 2022
    Inventors: David Medina CRUZ, Thomas J. WEBSTER
  • Publication number: 20220142916
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Application
    Filed: January 26, 2022
    Publication date: May 12, 2022
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. webster, Janet E. Davis
  • Publication number: 20220071919
    Abstract: Tellurium (Te) nanostructures are synthesized using green aloe vera chemistry methods, and the synthesized Te tructures provide methods of inhibiting bacterial cells and cancer cells without cytotoxicity towards normal cells. The aloe vera chemistry methods for synthesizing Te nanostructures do not produce toxic byproducts and do not require toxic reagents in comparison to traditional chemical synthetic methods for making Te nanostructures.
    Type: Application
    Filed: January 6, 2020
    Publication date: March 10, 2022
    Inventors: David Medina CRUZ, Ada Vernet CRUA, Thomas J. WEBSTER
  • Publication number: 20220008205
    Abstract: One embodiment of the present invention is directed to compositions and methods for enhancing attachment of soft tissues to a metal prosthetic device. In one embodiment a construct is provided comprising a metal implant having a porous metal region, wherein said porous region exhibits a nano-textured surface.
    Type: Application
    Filed: September 21, 2021
    Publication date: January 13, 2022
    Inventors: Thomas J. WEBSTER, Venu PERLA
  • Publication number: 20220010417
    Abstract: Aspects of the invention relate to a metal material and article made from the metal material having biological properties, such as antibiotic properties.
    Type: Application
    Filed: March 20, 2020
    Publication date: January 13, 2022
    Applicant: KOMATSUSEIKI KOSAKUSHO CO., LTD.
    Inventors: Fumie Yusa, Thomas J. Webster, Takafumi Komatsu
  • Publication number: 20210405523
    Abstract: A device such as a medical device and a method for making same provides a device surfaces modified by beam irradiation, such as a gas cluster ion beams or a neutral beam, to inhibit or delay attachment or activation or clotting of platelets or to match surface energy of the device to that of a protein with the property of inhibition of bacterial colonization that can coat the all or part of the device surface to effect such inhibition.
    Type: Application
    Filed: April 5, 2021
    Publication date: December 30, 2021
    Applicant: Exogenesis Corporation
    Inventors: Joseph Khoury, Sean R. Kirkpatrick, Michael J. Walsh, James G. Bachand, Allen R. Kirkpatrick, Thomas J. Webster
  • Patent number: 11186690
    Abstract: Methods for creating nanostructured surface features on polymers and polymer composites involve application of low pressure during curing of solid polymer material from a solvent solution. The resulting nanoscale surface features significantly decrease bacterial growth on the surface. Polymer materials having the nanoscale structuring can be used in implantable medical devices to inhibit bacterial growth and infection.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: November 30, 2021
    Assignee: Northeastern University
    Inventor: Thomas J. Webster